The Strategy Inc. blog includes valuable information for lifescience startups seeking industry guidance. Does your innovation improve patient outcomes or improve healthcare operations to make hospitals more efficient? Emerging lifescience entrepreneurs seek to ensure that the technologies they are developing will effectively address an unmet clinical need and track successful commercialization. Articles on this page focus on different aspects of development and cover the predictors of a clinician’s willingness to pay for an innovation, the expanding role of Key Opinion Leaders in innovation development and other aspects of the multifaceted process. These posts aim to provide guidance for the emerging entrepreneurs.
This page will be updated with expanded articles to support the development process for lifescience executives prioritizing resources and medical device consulting. Future articles are planned for “How to Determine the Valuation of a Preclinical Lifescience Innovation”, “Identifying Your Platform Technology Target Indication for Use”, “Projecting Adoption Curves for Early Stage Lifescience Technology” and more. If you have a specific topic that you would like to see included, send a message to firstname.lastname@example.org, and we will let you know when that article is posted.